Cargando…

RNA editing enzyme APOBEC3A promotes pro-inflammatory M1 macrophage polarization

Pro-inflammatory M1 macrophage polarization is associated with microbicidal and antitumor responses. We recently described APOBEC3A-mediated cytosine-to-uracil (C > U) RNA editing during M1 polarization. However, the functional significance of this editing is unknown. Here we find that APOBEC3A-m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alqassim, Emad Y., Sharma, Shraddha, Khan, A. N. M. Nazmul H., Emmons, Tiffany R., Cortes Gomez, Eduardo, Alahmari, Abdulrahman, Singel, Kelly L., Mark, Jaron, Davidson, Bruce A., Robert McGray, A. J., Liu, Qian, Lichty, Brian D., Moysich, Kirsten B., Wang, Jianmin, Odunsi, Kunle, Segal, Brahm H., Baysal, Bora E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822933/ https://www.ncbi.nlm.nih.gov/pubmed/33483601 http://dx.doi.org/10.1038/s42003-020-01620-x

Ejemplares similares

Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells
por: Sharma, Shraddha, et al.
Publicado: (2019)

Stem-loop structure preference for site-specific RNA editing by APOBEC3A and APOBEC3G
por: Sharma, Shraddha, et al.
Publicado: (2017)

Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer
por: Khan, Anm Nazmul H., et al.
Publicado: (2015)

A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer
por: McGray, A. J. R., et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells Modulate Immune Responses Independently of NADPH Oxidase in the Ovarian Tumor Microenvironment in Mice
por: Godoy, Heidi E., et al.
Publicado: (2013)

Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer
por: Singel, Kelly L., et al.
Publicado: (2018)

The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme
por: Sharma, Shraddha, et al.
Publicado: (2016)

APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages
por: Sharma, Shraddha, et al.
Publicado: (2015)

Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
por: Huang, Ruea-Yea, et al.
Publicado: (2016)

Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer
por: McGray, A. J. Robert, et al.
Publicado: (2019)

CXCR6 by increasing retention of memory CD8(+) T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer
por: Muthuswamy, Ravikumar, et al.
Publicado: (2021)

Transmission of X-linked Ovarian Cancer: Characterization and Implications
por: Etter, John Lewis, et al.
Publicado: (2020)

Computational detection and quantification of human and mouse neutrophil extracellular traps in flow cytometry and confocal microscopy
por: Ginley, Brandon G., et al.
Publicado: (2017)

The Role of C-to-U RNA Editing in Human Biodiversity
por: Van Norden, Melissa, et al.
Publicado: (2023)

Predictors of Immunosuppressive Regulatory T Lymphocytes in Healthy Women
por: Hampras, Shalaka S., et al.
Publicado: (2012)

Interferon Regulatory Factor-8 Is Important for Histone Deacetylase Inhibitor-Mediated Antitumor Activity
por: Banik, Debarati, et al.
Publicado: (2012)

Reprogramming the tumor microenvironment leverages CD8(+) T cell responses to a shared tumor/self antigen in ovarian cancer
por: Mistarz, Anna, et al.
Publicado: (2023)

Correction to: Tcf‑1 protects anti‑tumor TCR‑engineered CD8(+) T‑cells from GzmB mediated self‑destruction
por: Zangari, Brendan, et al.
Publicado: (2022)

Tcf-1 protects anti-tumor TCR-engineered CD8(+) T-cells from GzmB mediated self-destruction
por: Zangari, Brendan, et al.
Publicado: (2022)

APOBECs and Herpesviruses
por: Cheng, Adam Z., et al.
Publicado: (2021)

Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer
por: Starbuck, Kristen D., et al.
Publicado: (2018)

Succinate dehydrogenase inversely regulates red cell distribution width and healthy life span in chronically hypoxic mice
por: Baysal, Bora E., et al.
Publicado: (2022)

Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
por: Griffiths, Elizabeth A., et al.
Publicado: (2021)

Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy
por: Komorowski, Marcin P, et al.
Publicado: (2016)

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors
por: Yamauchi, Takayoshi, et al.
Publicado: (2021)

Immuno-stimultory/regulatory gene expression patterns in advanced ovarian cancer
por: Eng, Kevin H., et al.
Publicado: (2015)

Editorial: Neutrophils in Cancer
por: Segal, Brahm H., et al.
Publicado: (2022)

Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B
por: Shi, K., et al.
Publicado: (2016)

Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass
por: Buas, Matthew F., et al.
Publicado: (2021)

Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression
por: Warren, Cody J., et al.
Publicado: (2017)

BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control
por: McGray, A J Robert, et al.
Publicado: (2023)

NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury
por: Almyroudis, Nikolaos G., et al.
Publicado: (2013)

FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis
por: Waters, Catherine E., et al.
Publicado: (2014)

Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer
por: Matsuzaki, Junko, et al.
Publicado: (2022)

Isolated Colonic Lymphangiectasia Secondary to Submucosal Injection
por: Tomar, Sanjeevani, et al.
Publicado: (2022)

The Roles of APOBEC3G Complexes in the Incorporation of APOBEC3G into HIV-1
por: Ma, Jing, et al.
Publicado: (2013)

An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
por: Chan, Kin, et al.
Publicado: (2015)

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
por: Nik-Zainal, Serena, et al.
Publicado: (2014)

Restriction of MMTV by APOBEC3
por: Kraase, Martin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h206fvgf2lrlpgfg3s455l3s66